Selected research
Industry Research
Muscarinic Acetylcholine Receptor M4 Industry Research Report 2026
Market perspective
The global Muscarinic Acetylcholine Receptor M4 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Muscarinic Acetylcholine Receptor M4 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Muscarinic Acetylcholine Receptor M4 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Muscarinic Acetylcholine Receptor M4 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Muscarinic Acetylcholine Receptor M4 include Sumitomo Dainippon Pharma Co Ltd, AstraZeneca Plc, NeuroHealing Pharmaceuticals Inc, Karuna Pharmaceuticals Inc, Heptares Therapeutics Ltd and Anavex Life Sciences Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Muscarinic Acetylcholine Receptor M4 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Muscarinic Acetylcholine Receptor M4 Market by Company
Sumitomo Dainippon Pharma Co Ltd
AstraZeneca Plc
NeuroHealing Pharmaceuticals Inc
Karuna Pharmaceuticals Inc
Heptares Therapeutics Ltd
Anavex Life Sciences Corp
Muscarinic Acetylcholine Receptor M4 Segment by Type
Tropicamide
VU-0467154
ANAVEX-273
Others
Muscarinic Acetylcholine Receptor M4 Segment by Application
Amnesia
Cognitive Disorders
Psychosis
Others
Muscarinic Acetylcholine Receptor M4 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Muscarinic Acetylcholine Receptor M4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Muscarinic Acetylcholine Receptor M4 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Muscarinic Acetylcholine Receptor M4.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Muscarinic Acetylcholine Receptor M4 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Muscarinic Acetylcholine Receptor M4 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Muscarinic Acetylcholine Receptor M4 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tropicamide
- VU-0467154
- ANAVEX-273
- Others
Applications
- Amnesia
- Cognitive Disorders
- Psychosis
- Others
Companies covered
- Sumitomo Dainippon Pharma Co Ltd
- AstraZeneca Plc
- NeuroHealing Pharmaceuticals Inc
- Karuna Pharmaceuticals Inc
- Heptares Therapeutics Ltd
- Anavex Life Sciences Corp
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Muscarinic Acetylcholine Receptor M4 Market Size (2021-2032)
- 2.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales (2021-2032)
- 2.2.3 Global Muscarinic Acetylcholine Receptor M4 Market Average Price (2021-2032)
- 2.3 Muscarinic Acetylcholine Receptor M4 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tropicamide
- 2.3.3 VU-0467154
- 2.3.4 ANAVEX-273
- 2.3.5 Others
- 2.4 Muscarinic Acetylcholine Receptor M4 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Amnesia
- 2.4.3 Cognitive Disorders
- 2.4.4 Psychosis
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Muscarinic Acetylcholine Receptor M4 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Muscarinic Acetylcholine Receptor M4 Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Muscarinic Acetylcholine Receptor M4 Revenue of Manufacturers (2021-2026)
- 3.4 Global Muscarinic Acetylcholine Receptor M4 Average Price by Manufacturers (2021-2026)
- 3.5 Global Muscarinic Acetylcholine Receptor M4 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Muscarinic Acetylcholine Receptor M4, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Muscarinic Acetylcholine Receptor M4, Product Type & Application
- 3.8 Global Manufacturers of Muscarinic Acetylcholine Receptor M4, Established Date
- 3.9 Global Muscarinic Acetylcholine Receptor M4 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sumitomo Dainippon Pharma Co Ltd
- 4.1.1 Sumitomo Dainippon Pharma Co Ltd Company Information
- 4.1.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
- 4.1.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio
- 4.1.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
- 4.2 AstraZeneca Plc
- 4.2.1 AstraZeneca Plc Company Information
- 4.2.2 AstraZeneca Plc Business Overview
- 4.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Portfolio
- 4.2.5 AstraZeneca Plc Recent Developments
- 4.3 NeuroHealing Pharmaceuticals Inc
- 4.3.1 NeuroHealing Pharmaceuticals Inc Company Information
- 4.3.2 NeuroHealing Pharmaceuticals Inc Business Overview
- 4.3.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio
- 4.3.5 NeuroHealing Pharmaceuticals Inc Recent Developments
- 4.4 Karuna Pharmaceuticals Inc
- 4.4.1 Karuna Pharmaceuticals Inc Company Information
- 4.4.2 Karuna Pharmaceuticals Inc Business Overview
- 4.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio
- 4.4.5 Karuna Pharmaceuticals Inc Recent Developments
- 4.5 Heptares Therapeutics Ltd
- 4.5.1 Heptares Therapeutics Ltd Company Information
- 4.5.2 Heptares Therapeutics Ltd Business Overview
- 4.5.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio
- 4.5.5 Heptares Therapeutics Ltd Recent Developments
- 4.6 Anavex Life Sciences Corp
- 4.6.1 Anavex Life Sciences Corp Company Information
- 4.6.2 Anavex Life Sciences Corp Business Overview
- 4.6.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Portfolio
- 4.6.5 Anavex Life Sciences Corp Recent Developments
5 Global Muscarinic Acetylcholine Receptor M4 Market Scenario by Region
- 5.1 Global Muscarinic Acetylcholine Receptor M4 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021-2032
- 5.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021-2026
- 5.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2027-2032
- 5.3 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region: 2021-2032
- 5.3.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region: 2021-2026
- 5.3.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region: 2027-2032
- 5.4 North America Muscarinic Acetylcholine Receptor M4 Market Facts & Figures by Country
- 5.4.1 North America Muscarinic Acetylcholine Receptor M4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2032)
- 5.4.3 North America Muscarinic Acetylcholine Receptor M4 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Muscarinic Acetylcholine Receptor M4 Market Facts & Figures by Country
- 5.5.1 Europe Muscarinic Acetylcholine Receptor M4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2032)
- 5.5.3 Europe Muscarinic Acetylcholine Receptor M4 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Muscarinic Acetylcholine Receptor M4 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Muscarinic Acetylcholine Receptor M4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Muscarinic Acetylcholine Receptor M4 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Muscarinic Acetylcholine Receptor M4 Market Facts & Figures by Country
- 5.7.1 South America Muscarinic Acetylcholine Receptor M4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2032)
- 5.7.3 South America Muscarinic Acetylcholine Receptor M4 Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Muscarinic Acetylcholine Receptor M4 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Muscarinic Acetylcholine Receptor M4 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Muscarinic Acetylcholine Receptor M4 Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032)
- 6.1.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2021-2032)
- 6.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032)
- 6.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2021-2032)
- 6.3 Global Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032)
- 7.1.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2021-2032)
- 7.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032)
- 7.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2021-2032)
- 7.3 Global Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Muscarinic Acetylcholine Receptor M4 Value Chain Analysis
- 8.1.1 Muscarinic Acetylcholine Receptor M4 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Muscarinic Acetylcholine Receptor M4 Production Mode & Process
- 8.2 Muscarinic Acetylcholine Receptor M4 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Muscarinic Acetylcholine Receptor M4 Distributors
- 8.2.3 Muscarinic Acetylcholine Receptor M4 Customers
9 Global Muscarinic Acetylcholine Receptor M4 Analyzing Market Dynamics
- 9.1 Muscarinic Acetylcholine Receptor M4 Industry Trends
- 9.2 Muscarinic Acetylcholine Receptor M4 Industry Drivers
- 9.3 Muscarinic Acetylcholine Receptor M4 Industry Opportunities and Challenges
- 9.4 Muscarinic Acetylcholine Receptor M4 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst